Real option as strategic technology uncertainty reduction mechanism: Inter-firm investment strategy by pharmaceuticals

Technology Analysis and Strategic Management

Volumn 23, Issue 5, 2011, Pages 489-507

  Malik, Tariq ^a  

^a DONGBEI UNIVERSITY OF FINANCE AND ECONOMICS   (China)

Author keywords

Management of external technology uncertainty; Real option investment; Uncertainty reduction mechanisms

Indexed keywords

INVESTMENT; LIFE CYCLE ANALYSIS; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT; TECHNOLOGICAL DEVELOPMENT; UNCERTAINTY ANALYSIS;

EID: 79957801388     PISSN: 09537325     EISSN: 14653990     Source Type: Journal    
DOI: 10.1080/09537325.2011.565660     Document Type: Article

References (72)

1. Abernathy, W.J., and J.M. Utterback. 1978. The pattern of industrial innovation. Technological Review 80: 41-47.
2. Adner, R., and D. Levinthal. 2004. What is not a real option: Considering boundaries for the application of real options to business strategy. Academy of Management Review 29, no. 1: 120-160.
3. Ahuja, G. 2000. The duality of collaboration: Inducement and opportunities in the formation of interfirm linkages. Strategic Management Journal 21: 317-343.
4. Aiken, L.S., and G.West. 1991. Multiple regression: Testing and interpreting interactions. Newbury Park, CA: Sage.
5. Amram, M., and N. Kulatilaka. 1999. Managing strategic investment in an uncertain world. Cambridge, MA: Harvard Business School Press.
6. Arora, A., and A. Gambardella. 1994. Evaluating technological information and utilizing it: Scientific knowledge, technological capability, and external linkages in biotechnology. Journal of Economic Behavior & Organization 24, no. 1: 91-114.
7. Arrow, K. 1974. The limits of organization. NewYork: Norton.
8. Baird, I., and H. Thomas. 1985. Toward a contingency model of strategic risk taking. Academy of Management Review 10: 230-243.
9. Baum, J., T. Calabrese, and B. Silverman. 2000. Don't go it alone: Alliance network composition and startups performance in canadian biotechnology. Strategic Management Journal 21, no. 3: 267-294.
10. Beckman, C., P. Haunschild, and D. Phillips. 2004. Friends or strangers? Firm-specific uncertainty, market uncertainty, and network partner selection. Organization Science 15, no. 3: 259-275.
11. Berger, C.R. 1986. Uncertain outcome values in predicted relationships: Uncertainty reduction theory then and now. Human Communication Research 13: 34-38.
12. Berger, C.R., and R.J. Calabrese. 1975. Some explorations in initial interaction and beyond: Toward a developmental theory of interpersonal communication. Human Communication Research 1: 99-112.
13. Bowman, E.H., and D. Hurry. 1993. Strategy through the options lens: An integrated view of resource investments and the incremental-choice process. Academy of Management Review 18: 760-782.
14. Bradac, J.J. 2001. Theory comparison: Uncertainty reduction, problematic integration, uncertainty management, and other curious constructs. The Journal of Communication 51, no. 3: 456-476.
15. Brashers, D.E. (2001). Communication and uncertainty management. Journal of Communication, 51, 477-497.
16. Casper, S. 2001. The legal framework for corporate goverance: Contact law and company strategies in Germany and the United States. In Varieties of capitalism: The institutional foundations of comparative advantage, ed. P. Hall and D. Soskice, 387-416. Oxford: Oxford University Press.
17. Chi, T., and D.J. McGuire. 1996. Collaborative ventures and value of learning: Integrating the transaction cost and strategic option persepctives on foreign market entry. Journal of International Business Studies 27: 285-308.
18. Child, J., D. Faulkner, and S. Tallman. 2005. Cooperative strategy: Managing alliances, networks, and joint ventures. Oxford: Oxford University Press.
19. Contractor, F.J., and P. Lorange, eds. 2002. Cooperative strategies and alliances. Boston, MA: Elsevier Science.
20. DiMasi, J.A., R.W. Hansen, and H.G. Grabowski. 2003. The price of innovation: New estimates of drug development costs. Journal of Health Economics 22: 151-185.
21. DiMasi, J.A., R.W. Hansen, H.G. Grabowski, and L. Lasagna. 1995. Research and development costs for new drugs by therapeutic category. Pharmaco Economics 7, no. 2: 152-169.
22. Doz, Y.L., and G. Hamel. 1998. Alliance advantage: The art of creating value through partnering. Boston, MA: Harvard Business School Press.
23. Dyer, J.H., and H. Singh. 1998. The relational view: Cooperative strategy and sources of interorganizational competitive advantage. Academy of Management Review 23, no. 4: 660-679.
24. Farace, R.V., P.R. Monge, and H. Russell. 1977. Communicating and organizing. Reading, MA: Addison-Wesley.
25. Fidler, L.A., and J.D. Johnson. 1984. Communication and innovation implementation. Academy of Management Review 9, no. 4: 704-711.
26. Folta, T. 1998. Governance and uncertainty: The trade-off between administrative control and commitment. Strategic Management Journal 19: 1007-1028.
27. Folta, T., and K.D. Miller. 2002. Real options in equity partnership. Strategic Management Journal 23, no. 1: 77-88.
28. Greenwood, R., S.X. Li, R. Prakash, and D.L. Deephouse. 2005. Reputation, diversification, and organizational explanation of performance in professional service firms. Organization Science 16, no. 6: 661-73.
29. Gulati, R., T. Khanna, and N. Nohira. 1994. Unilateral commitments and the importance of process in alliances. Sloan Management Review, 35: 61-69.
30. Halliday, M.A.K. 1994. An introduction to functional grammar (2nd ed.). London: Edward Arnold.
31. Hatfield, D.E., L.F. Tegarden, and A.E. Echols. 2001. Facing the uncertain environment from technological discontinuities: Hedging as a technology strategy. The Journal of High Technology Management Research 12, no. 1: 63-76.
32. Hennart, J.-F., and S. Reddy. 1997. The choice between merger/acquisitions and joint ventures: The case of Japanese investors in the United States. Strategic Management Journal 97, no. 18: 1-12.
33. Kim, D.J., and B. Kogut. 1996. Technological platforms and diversification. Organization Science 7, no. 3: 283-301.
34. Klepper, S. 1996. Entry, exit, growth, and innovation over the product life cycle. American Economic Review 86, no. 3: 562-583.
35. Kneller, R. 2003. Autarkic drug discovery in Japanese pharmaceutical companies: Insights into national differences in industrial Innovation. Research Policy 32, no. 10: 1805-1827.
36. Kogut, B. 1988. Joint ventures: Theoretical and empirical perspectives. Strategic Management Journal 3: 319-332.
37. Kogut, B. 1991. Joint ventures and the option to expand and Management Science 37, no. 1: 19-33.
38. Kogut, B. 2004. Joint ventures: Theoretical and empirical perspectives. In Strategic Alliances: Theory and Evidence, ed. J.J. Reuer, 48-68. Oxford: Oxford University Press.
39. Kogut, B., and N. Kulatilaka. 1994. Operating flexibility, global manufacturing, and the option value of a multinational network. Management Science 40, no. 1: 123-139.
40. Kumar, M.V.S. 2005. The value from acquiring and divesting a joint venture: A real options approach. Strategic Management Journal 26, no. 4: 321-331.
41. Leiblein, M.J. 2003. The choice of organizational governance form and performance: Predictions from transaction cost, resource-based, and real options theories. Journal of Management 29, no. 6: 937-961.
42. Leiblein, M.J., and Miller, D.J. 2003. An empirical examination of transaction- and firm-level influences on the vertical boundaries of the firm. Strategic Management Journal 24, no. 9: 839-860.
43. Levinthal, D. 1991. Random walks and organizational mortality. Administrative Science Quarterly 36: 397-420.
44. Mangum, G.L., S.-Y. Kim, and S. Tallman. 1996. Transnational marriages in the steel industry: Experience and lessons for global business. Westport, CT: Quorum.
45. McGrath, R.G. 1997. A real options logic for initiating technology positioning investments. Academy of Management Review 22, no. 4: 974-996.
46. McGrath, R.G., and A. Nerkar. 2004. Real options reasoning and a new look at the R&D investment strategies of pharmaceutical firms. Strategic Management Journal 25, no. 1: 1-21.
47. Miller, K.D., and T. Folta. 2002. Real options in equity partnerships. Strategic Management Journal 23: 77-89.
48. Morroni, M. 2007. Complementarities among capability, transaction and scale-scope considerations in determining organizational boundaries. Technology Analysis & Strategic Management 19, no. 1: 31-44.
49. Pfeffer, J., and G. Salancik. 1978. The external control of organizations. NewYork: Harper and Row.
50. Pisano, G. 1989. Using equity to support exchange: Evidence from biotechnology industry. Journal of Law, Economics and Organization 5, no. 1: 109-126.
51. Podolny, J.M., and M. Hill-Popper. 2004. Hedonic and transcendent conceptions of value. Industrial and Corporate Change 13, no. 1: 91-116.
52. Powell, W.W., K.W. Koput, and L. Smith-Doerr. 1996. Inter-organizational collaboration and the locus of innovation: Networks of learning in biotechnology. Administrative Science Quarterly 41: 116-145.
53. Ring, P.S., and A.H. Van deVen. 1992. Structuring cooperative relationships between organizations. Strategic Management Journal 13: 483-498.
54. Rothaermel, F.T. 2001. Incumbent's advantage through exploiting complementary assets via interfirm cooperation. Strategic Management Journal 22, no. 6/7: 687-700.
55. Rothaermel, F.T., and D.L. Deeds. 2004. Exploration and exploitation alliances in biotechnology: A system of new product development. Strategic Management Journal 25, no. 3: 201-222.
56. Singh, J., D. Tucker, and R. House. 1986. Organizational change and organizational mortality. Administrative Science Quarterly 31: 587-611.
57. Slater, S.F., and J.C. Narver. 1998. Customer-led and market-oriented: Let's not confuse the two. Strategic Management Journal 19, no. 10: 1001-1006.
58. Smith, R.D., C. Correa, and C. Oh. 2009. Trade, TRIPS, and pharmaceuticals. Lancet 373(February): 684-91.
59. Stuart, T.E., S. Ozdemir, and W. Ding. 2007.Vertical alliance networks: The case of university-biotechnology-pharmaceutical alliance chains. Research Policy 36: 477-498.
60. Teece, D. 2000. Managing intellectual capital: Organizational, strategic, and policy dimensions. Oxford: Oxford University Press.
61. Teece, D.J. 1980. Economies of scope and the scope of the enterprise. Journal of Economic Behavior & Organization 1: 223-233.
62. Teece, D.J. 1989. Inter-organizational requirements of the innovation process. (Special Issue: Competitiveness, technology and productivity). Managerial and Decision Economics, 10: 35-42.
63. Teece, D.J. 1992. Competition, cooperation, and innovation: Organizational arrangements for regimes of rapid technological progress. Journal of Economic Behavior and Organization 18, no. 1: 1-25.
64. Tushman, M. 1977. Special boundary roles in the innovation process. Administrative Science Quarterly 22: 587-605.
65. Tushman, M. 1979. Impacts of perceived environmental variability on patterns of work related communication. Academy of Management Journal 22, no. 3: 482-500.
66. Tversky, A., and D. Kahneman. 1992. Advances in prospect theory: Cumulative representation of uncertainty. Journal of Risk and Uncertainty 5: 297-323.
67. Utterback, J.M. 1994. Mastering the dynamics of innovation: How companies can seize opportunities in the face of technology. Boston, MA: Harvard Business School Press.
68. Utterback, J.M. 1996. Mastering the dynamics of innovation. Boston, MA: Harvard Business School Press.
69. Utterback, J.M. and A. Afuah. 1998. The dynamic 'dimand': A technological perspective. Economic Innovation & New Technology 6: 183-199.
70. Vassolo, R., J. Anand, and T. Folta. 2004. Non-additivity in portforfolios of exploration activities: A real options-based analysis of equity allinaces in biotechnology. Strategic Managment Journal 25: 1045-1061.
71. Williamson, O.E. 1985. The economic institutions of capitalism. NewYork: The Free Press.
72. Williamson, O.E. 1991. Strategizing, economizing, and economic organization. Strategic Management Journal 12: 75-94.